Teh Seng Pharmaceutical Mfg Co (ROCO:7860) EPS without NRI: NT$3.21 (TTM As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:7860 Teh Seng Pharmaceutical Mfg Co Ltd ROCO:7860
22 GF Score
Price NT$73.10
! 7 Warning Signs
View Full Analysis

What is Teh Seng Pharmaceutical Mfg Co EPS without NRI?

Teh Seng Pharmaceutical Mfg Co ROCO:7860 -5.06% 22 EPS without NRI is NT$3.21 as of Dec. 2025. GuruFocus rates ROCO:7860 with a GF Score™ of 22/100. The stock has 7 warning signs investors should review. Among 789 Drug Manufacturers companies, Teh Seng Pharmaceutical Mfg Co ranks worse than 126742.59% on this metric.

Teh Seng Pharmaceutical Mfg Co's earnings per share without non-recurring items for the six months ended in Dec. 2025 was NT$2.17. Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Dec. 2025 was NT$3.21.

During the past 12 months, Teh Seng Pharmaceutical Mfg Co's average earnings per share (NRI) Growth Rate was -41.50% per year. During the past 10 years, the average earnings per share (NRI) Growth Rate was 0.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.

The historical rank and industry rank for Teh Seng Pharmaceutical Mfg Co's EPS without NRI or its related term are showing as below:

ROCO:7860's 3-Year EPS without NRI Growth Rate is not ranked *
in the Drug Manufacturers industry.
Industry Median: 9.6
* Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.

Teh Seng Pharmaceutical Mfg Co's EPS (Diluted) for the six months ended in Dec. 2025 was NT$2.17. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was NT$3.21.

Teh Seng Pharmaceutical Mfg Co's EPS (Basic) for the six months ended in Dec. 2025 was NT$2.17. Its EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2025 was NT$3.22.


Teh Seng Pharmaceutical Mfg Co  (ROCO:7860) EPS without NRI Explanation

EPS without NRI removes onetime and unusual items from EPS, to provide investors with a more accurate measure of the company’s true earnings. The earnings are adjusted for items that are irregular or unusual in nature, and/or are non-recurring. This is calculated using Net Income (Continuing Operations) plus/minus any tax affected unusual Items and Goodwill Impairments/Write Offs. This can be used to fairly measure a company's profitability.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Teh Seng Pharmaceutical Mfg Co EPS without NRI Related Terms


Teh Seng Pharmaceutical Mfg Co EPS without NRI Historical Data

* Premium members only.

The historical data trend for Teh Seng Pharmaceutical Mfg Co's EPS without NRI can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Teh Seng Pharmaceutical Mfg Co EPS without NRI Chart

Teh Seng Pharmaceutical Mfg Co Annual Data
Trend Dec23 Dec24 Dec25
EPS without NRI
3.45 5.49 3.21

Teh Seng Pharmaceutical Mfg Co Semi-Annual Data
Dec23 Jun24 Dec24 Jun25 Dec25
EPS without NRI 0.00 2.02 3.46 1.04 2.17

ROCO:7860 vs ZTS: EPS without NRI Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Teh Seng Pharmaceutical Mfg Co's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Teh Seng Pharmaceutical Mfg Co PE Ratio without NRI vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Teh Seng Pharmaceutical Mfg Co's PE Ratio without NRI distribution charts can be found below:

* The bar in red indicates where Teh Seng Pharmaceutical Mfg Co's PE Ratio without NRI falls into.


ROCO:7860
22GF Score
Teh Seng Pharmaceutical Mfg Co Ltd ROCO:7860
EPS without NRI is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Teh Seng Pharmaceutical Mfg Co EPS without NRI Calculation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock.

EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was NT$3.21

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS without NRI →
What does a EPS without NRI of NT$3.21 mean?
Teh Seng Pharmaceutical Mfg Co (ROCO:7860) has a EPS without NRI of NT$3.21 as of Dec. 2025. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Teh Seng Pharmaceutical Mfg Co and its competitors. According to the industry distribution chart, Teh Seng Pharmaceutical Mfg Co ranks #999999 out of 789 companies in the Drug Manufacturers industry.
Is Teh Seng Pharmaceutical Mfg Co's EPS without NRI too high?
Teh Seng Pharmaceutical Mfg Co's current EPS without NRI is NT$3.21. Based on the distribution chart, Teh Seng Pharmaceutical Mfg Co ranks #999999 out of 789 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Teh Seng Pharmaceutical Mfg Co has a GF Score™ of 22/100, reflecting its overall financial health beyond just this single metric.
How does Teh Seng Pharmaceutical Mfg Co's EPS without NRI compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Teh Seng Pharmaceutical Mfg Co ranks #999999 out of 789 companies for EPS without NRI. This places Teh Seng Pharmaceutical Mfg Co in the lower half of its industry. The industry median EPS without NRI is 9.60. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS without NRI for a Drug Manufacturers company?
The median EPS without NRI among Drug Manufacturers companies is 9.60, based on 789 companies in the industry. Companies in the top quartile (top 25%) have a EPS without NRI significantly above this median, while those in the bottom quartile fall well below. However, EPS without NRI should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS without NRI mean?
A high EPS without NRI can signal that a stock is expensive relative to its fundamentals. EPS without NRI represents per-share earnings excluding one-time charges. View historical data on Teh Seng Pharmaceutical Mfg Co and its competitors. For the Drug Manufacturers industry, the median EPS without NRI is 9.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Teh Seng Pharmaceutical Mfg Co's current EPS without NRI is NT$3.21. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Teh Seng Pharmaceutical Mfg Co stock overvalued right now?
Teh Seng Pharmaceutical Mfg Co (ROCO:7860) has a current EPS without NRI of NT$3.21. The current EPS without NRI is NT$3.21. Teh Seng Pharmaceutical Mfg Co's overall GF Score™ is 22/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS without NRI calculated?
EPS without NRI is calculated from a company's financial statements. For Teh Seng Pharmaceutical Mfg Co (ROCO:7860), the current EPS without NRI is NT$3.21 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Teh Seng Pharmaceutical Mfg Co Business Description

Address No.42,Huan Gong Road, Yong Kang District, Tainan, TWN, 710001
Teh Seng Pharmaceutical Mfg Co Ltd is engaged in the development and manufacturing of various pain relieving patches, cosmetic patches and biotechnology products. Its products include: Hydrogel Patches, Oil-Based Patches, Hot-Melt Patches, CMO & CRO for Transdermal Patch, Oral Film & Sublingual, Cosmetic Patches, Biotechnology Products and Daily Supplements.
22GF Score

Get the complete analysis for ROCO:7860

EPS without NRI is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$73.10
Price